RBC Capital Assumes Agile Therapeutics (AGRX) at Outperform
Tweet Send to a Friend
RBC Capital analyst Daniel Busb assumes coverage on Agile Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
